>sp|P03378|ENV_HV1A2 Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) OX=11685 GN=env PE=1 SV=1
MKVKGTRRNYQHLWRWGTLLLGMLMICSATEKLWVTVYYGVPVWKEATTTLFCASDARAY
DTEVHNVWATHACVPTDPNPQEVVLGNVTENFNMWKNNMVEQMQEDIISLWDQSLKPCVK
LTPLCVTLNCTDLGKATNTNSSNWKEEIKGEIKNCSFNITTSIRDKIQKENALFRNLDVV
PIDNASTTTNYTNYRLIHCNRSVITQACPKVSFEPIPIHYCTPAGFAILKCNNKTFNGKG
PCTNVSTVQCTHGIRPIVSTQLLLNGSLAEEEVVIRSDNFTNNAKTIIVQLNESVAINCT
RPNNNTRKSIYIGPGRAFHTTGRIIGDIRKAHCNISRAQWNNTLEQIVKKLREQFGNNKT
IVFNQSSGGDPEIVMHSFNCRGEFFYCNTTQLFNNTWRLNHTEGTKGNDTIILPCRIKQI
INMWQEVGKAMYAPPIGGQISCSSNITGLLLTRDGGTNVTNDTEVFRPGGGDMRDNWRSE
LYKYKVIKIEPLGIAPTKAKRRVVQREKRAVGIVGAMFLGFLGAAGSTMGAVSLTLTVQA
RQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARVLAVERYLRDQQLLGIWGCSGK
LICTTAVPWNASWSNKSLEDIWDNMTWMQWEREIDNYTNTIYTLLEESQNQQEKNEQELL
ELDKWASLWNWFSITNWLWYIKIFIMIVGGLVGLRIVFAVLSIVNRVRQGYSPLSFQTRL
PVPRGPDRPDGIEEEGGERDRDRSVRLVDGFLALIWEDLRSLCLFSYRRLRDLLLIAART
VEILGHRGWEALKYWWSLLQYWIQELKNSAVSWLNATAIAVTEGTDRVIEVAQRAYRAIL
HIHRRIRQGLERLLL
>sp|P03375|ENV_HV1B1 Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype B (isolate BH10) OX=11678 GN=env PE=1 SV=1
MRVKEKYQHLWRWGWRWGTMLLGMLMICSATEKLWVTVYYGVPVWKEATTTLFCASDAKA
YDTEVHNVWATHACVPTDPNPQEVVLVNVTENFNMWKNDMVEQMHEDIISLWDQSLKPCV
KLTPLCVSLKCTDLKNDTNTNSSSGRMIMEKGEIKNCSFNISTSIRGKVQKEYAFFYKLD
IIPIDNDTTSYTLTSCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCT
NVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVIRSANFTDNAKTIIVQLNQSVEINCTRPN
NNTRKSIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNNTLKQIDSKLREQFGNNKTII
FKQSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWFNSTWSTKGSNNTEGSDTITLPCRI
KQIINMWQEVGKAMYAPPISGQIRCSSNITGLLLTRDGGNSNNESEIFRPGGGDMRDNWR
SELYKYKVVKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGAASMTLTVQ
ARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSG
KLICTTAVPWNASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQEL
LELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSVVNRVRQGYSPLSFQTH
LPIPRGPDRPEGIEEEGGERDRDRSIRLVNGSLALIWDDLRSLCLFSYHRLRDLLLIVTR
IVELLGRRGWEALKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRVIEVVQGAYRAI
RHIPRRIRQGLERILL
>sp|P03377|ENV_HV1BR Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) OX=11686 GN=env PE=1 SV=1
MRVKEKYQHLWRWGWKWGTMLLGILMICSATEKLWVTVYYGVPVWKEATTTLFCASDAKA
YDTEVHNVWATHACVPTDPNPQEVVLVNVTENFNMWKNDMVEQMHEDIISLWDQSLKPCV
KLTPLCVSLKCTDLGNATNTNSSNTNSSSGEMMMEKGEIKNCSFNISTSIRGKVQKEYAF
FYKLDIIPIDNDTTSYTLTSCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNG
TGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVIRSANFTDNAKTIIVQLNQSVEIN
CTRPNNNTRKSIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNATLKQIASKLREQFGN
NKTIIFKQSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWFNSTWSTEGSNNTEGSDTIT
LPCRIKQFINMWQEVGKAMYAPPISGQIRCSSNITGLLLTRDGGNNNNGSEIFRPGGGDM
RDNWRSELYKYKVVKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGARSM
TLTVQARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGI
WGCSGKLICTTAVPWNASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEK
NEQELLELDKWASLWNWFNITNWLWYIKIFIMIVGGLVGLRIVFAVLSIVNRVRQGYSPL
SFQTHLPTPRGPDRPEGIEEEGGERDRDRSIRLVNGSLALIWDDLRSLCLFSYHRLRDLL
LIVTRIVELLGRRGWEALKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRVIEVVQG
ACRAIRHIPRRIRQGLERILL
>sp|P05879|ENV_HV1C4 Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype B (isolate CDC-451) OX=11687 GN=env PE=1 SV=1
MAMRAKGIRKNCQHLWRWGTMLLGMLMICSAAANLWVTVYYGVPVWKEATTTLFCASDAK
AYDTEAHNVWATHACVPTNPNPQEVVLENVTENFNMWKNNMVEQMHEDIISLWDQSLKPC
VKLTPLCVTLNCTDLNTNNTTNTTELSIIVVWEQRGKGEMRNCSFNITTSIRDKVQREYA
LFYKLDVEPIDDNKNTTNNTKYRLINCNTSVITQACPKVSFEPIPIHYCTPTGFALLKCN
DKKFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVIRSENFTNNAKTIIVQLN
VSVEINCTRPNNHTRKRVTLGPGRVWYTTGEILGNIRQAHCNISRAQWNNTLQQIATTLR
EQFGNKTIAFNQSSGGDPEIVMHSFNCGGEFFYCNSTQLFNSAWNVTSNGTWSVTRKQKD
TGDIITLPCRIKQIINRWQVVGKAMYALPIKGLIRCSSNITGLLLTRDGGGENQTTEIFR
PGGGDMRDNWRSELYKYKVVKIEPLGVAPTKAKRRVVQREKRAVGMLGAMFLGFLGAAGS
TMGATSMALTVQARQLLSGIVQQQNNLLRAIKAQQHLLQLTVWGIKQLQARILAVERYLK
DQQLLGFWGCSGKLICTTAVPWNASWSNKTLDQIWNNMTWMEWDREIDNYTHLIYTLIEE
SQNQQEKNQQELLQLDKWASLWTWSDITKWLWYIKIFIMIVGGLIGLRIVFAVLSIVNRV
RQGYSPLSFQTLLPNPRGPDRPEGTEEGGGERGRDGSTRLVHGFLALVWDDLRSLCLFSY
HRLRDLLLIVARIVELLGRRGWEVLKYWWNLLQYWSQELKNSAVSLVNVTAIAVAEGTDR
VIEVVQRIYRAFLHIPRRIRQGFERALL
>sp|P04581|ENV_HV1EL Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype D (isolate ELI) OX=11689 GN=env PE=3 SV=1
MRARGIERNCQNWWKWGIMLLGILMTCSAADNLWVTVYYGVPVWKEATTTLFCASDAKSY
ETEAHNIWATHACVPTDPNPQEIALENVTENFNMWKNNMVEQMHEDIISLWDQSLKPCVK
LTPLCVTLNCSDELRNNGTMGNNVTTEEKGMKNCSFNVTTVLKDKKQQVYALFYRLDIVP
IDNDSSTNSTNYRLINCNTSAITQACPKVSFEPIPIHYCAPAGFAILKCRDKKFNGTGPC
TNVSTVQCTHGIRPVVSTQLLLNGSLAEEEVIIRSENLTNNAKNIIAHLNESVKITCARP
YQNTRQRTPIGLGQSLYTTRSRSIIGQAHCNISRAQWSKTLQQVARKLGTLLNKTIIKFK
PSSGGDPEITTHSFNCGGEFFYCNTSGLFNSTWNISAWNNITESNNSTNTNITLQCRIKQ
IIKMVAGRKAIYAPPIERNILCSSNITGLLLTRDGGINNSTNETFRPGGGDMRDNWRSEL
YKYKVVQIEPLGVAPTRAKRRVVEREKRAIGLGAMFLGFLGAAGSTMGARSVTLTVQARQ
LMSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKHI
CTTNVPWNSSWSNRSLNEIWQNMTWMEWEREIDNYTGLIYSLIEESQTQQEKNEKELLEL
DKWASLWNWFSITQWLWYIKIFIMIIGGLIGLRIVFAVLSLVNRVRQGYSPLSFQTLLPA
PRGPDRPEGTEEEGGERGRDRSVRLLNGFSALIWDDLRSLCLFSYHRLRDLILIAVRIVE
LLGRRGWDILKYLWNLLQYWSQELRNSASSLFDAIAIAVAEGTDRVIEIIQRACRAVLNI
PRRIRQGLERSLL
>tr|B2CPZ5|B2CPZ5_9HIV1 Envelope glycoprotein gp160 OS=Human immunodeficiency virus 1 OX=11676 GN=env PE=3 SV=1
MRVKEKYQHLWRWGWRWGTMLLGMLMICSATEKLWVTVYYGVPVWKEATTTLFCASDAKA
YDTEVHNVWATHACVPTDPNPQEVVLVNVTENFNMWKNDMVEQMHEDIISLWDQSLKPCV
KLTPLCVSLKCTDLKNDTNTNSSSGRMIMEKGEIKNCSFNISTSIRGKVQKEYAFFYKLD
IIPIDNDTTSYTLTSCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCT
NVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVIRSVNFTDNAKTIIVQLNTSVEINCTRPN
NNTRKKIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNATLKQIASKLREQFGNNKTII
FKQSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWFNSTWSTEGSNNTEGSDTITLPCRI
KQFINMWQEVGKAMYAPPISGQIRCSSNITGLLLTRDGGNNNNGSEIFRPGGGDMRDNWR
SELYKYKVVKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGAASMTLTVQ
ARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSG
KLICTTAVPWNASWSNKSLEQIWNHTTWMEWDREINNYTSLIHSLIEESQNQQEKNEQEL
LELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSVVNRVRQGYSPLSFQTH
LPIPRGPDRPEGIEEEGGERDRDRSIRLVNGSLALIWDDLRSLCLFSYHRLRDLLLIVTR
IVELLGRRGWEALKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRVIEVVQEAYRAI
RHIPRRIGQGLERILL
>tr|Q6BC22|Q6BC22_9HIV1 Envelope glycoprotein gp160 (Fragment) OS=Human immunodeficiency virus 1 OX=11676 GN=env PE=3 SV=1
MRVKGIRKNYQHLWKGGILLLGTLMICSAVEKLWVTVYYGVPVWKETTTTLFCASDAKAY
DTEVHNVWATHACVPTDPNPQEVVLENVTEDFNMWKNNMVEQMQEDVINLWDQSLKPCVK
LTPLCVTLNCKDVNATNTTSSSEGMMERGEIKNCSFNITKSIRDKVQKEYALFYKLDVVP
IDNKNNTKYRLISCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGKGQCKNV
STVQCTHGIRPVVSTQLLLNGSLAEEKVVIRSDNFTDNAKTIIVQLNESVKINCTRPSNN
TRKSIHIGPGRAFYTTGEIIGDIRQAHCNISRAQWNNTLKQIVEKLREQFNNKTIVFTHS
SGGDPEIVMHSFNCGGEFFYCNSTQLFNSTWNDTEKSSGTEGNDTIILPCRIKQIINMWQ
EVGKAMYAPPIKGQIRCSSNITGLLLTRDGGKNESEIEIFRPGGGDMRDNWRSELYKYKV
VKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGAASMTLTVQARQLLSGI
VQQQNNLLRAIEAQQHMLQLTVWGIKQLQARVLAVERYLKDQQLMGIWGCSGKLICTTAV
PWNTSWSNKSLDSIWNNMTWMEWEKEIENYTNTIYTLIEESQIQQEKNEQELLELDKWAS
LWNWFDITKWLWYIKIFIMIVGGLIGLRIVFSVLSIVNRVRQGYSPLSFQTLLPATRGPD
RPEGIEEEGGERDRDRSGQLVNGFLALIWVDLRSLFLFSYHRLRDLLLTVTRIVELLGRR
GWEILKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRIIEVVQRVYRAILHIPTRIR
QGLERALL
>sp|P05877|ENV_HV1MN Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype B (isolate MN) OX=11696 GN=env PE=1 SV=1
MRVKGIRRNYQHWWGWGTMLLGLLMICSATEKLWVTVYYGVPVWKEATTTLFCASDAKAY
DTEVHNVWATQACVPTDPNPQEVELVNVTENFNMWKNNMVEQMHEDIISLWDQSLKPCVK
LTPLCVTLNCTDLRNTTNTNNSTANNNSNSEGTIKGGEMKNCSFNITTSIRDKMQKEYAL
LYKLDIVSIDNDSTSYRLISCNTSVITQACPKISFEPIPIHYCAPAGFAILKCNDKKFSG
KGSCKNVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVIRSENFTDNAKTIIVHLNESVQIN
CTRPNYNKRKRIHIGPGRAFYTTKNIIGTIRQAHCNISRAKWNDTLRQIVSKLKEQFKNK
TIVFNQSSGGDPEIVMHSFNCGGEFFYCNTSPLFNSTWNGNNTWNNTTGSNNNITLQCKI
KQIINMWQEVGKAMYAPPIEGQIRCSSNITGLLLTRDGGKDTDTNDTEIFRPGGGDMRDN
WRSELYKYKVVTIEPLGVAPTKAKRRVVQREKRAAIGALFLGFLGAAGSTMGAASVTLTV
QARLLLSGIVQQQNNLLRAIEAQQHMLQLTVWGIKQLQARVLAVERYLKDQQLLGFWGCS
GKLICTTTVPWNASWSNKSLDDIWNNMTWMQWEREIDNYTSLIYSLLEKSQTQQEKNEQE
LLELDKWASLWNWFDITNWLWYIKIFIMIVGGLVGLRIVFAVLSIVNRVRQGYSPLSLQT
RPPVPRGPDRPEGIEEEGGERDRDTSGRLVHGFLAIIWVDLRSLFLFSYHHRDLLLIAAR
IVELLGRRGWEVLKYWWNLLQYWSQELKSSAVSLLNATAIAVAEGTDRVIEVLQRAGRAI
LHIPTRIRQGLERALL
>sp|P04579|ENV_HV1RH Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype B (isolate RF/HAT3) OX=11701 GN=env PE=3 SV=1
MRVMEMRKNCQHLWKWGTMLLGMLMICSAAEDLWVTVYYGVPVWKEATTTLFCASEAKAY
KTEVHNVWAKHACVPTDPNPQEVLLENVTENFNMWKNNMVEQMHEDIISLWDQSLKPCVK
LTPLCVTLNCTDANLNGTNVTSSSGGTMMENGEIKNCSFQVTTSRRDKTQKKYALFYKLD
VVPIEKGNISPKNNTSNNTSYGNYTLIHCNSSVITQACPKVSFEPIPIHYCTPAGFAILK
CNDKKFNGTGPCKNVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVIRSENFTDNVKTIIVQ
LNASVQINCTRPNNNTRKSITKGPGRVIYATGQIIGDIRKAHCNLSRAQWNNTLKQVVTK
LREQFDNKTIVFTSSSGGDPEIVLHSFNCGGEFFYCNTTQLFNSTWNSTEGSNNTGGNDT
ITLPCRIKQIVNMWQEVGKAMYAPPISGQIKCISNITGLLLTRDGGEDTTNTTEIFRLGG
GNMRDNWRSELYKYKVVRIEPLGVAPTRAKRRVVQREKRAVGTIGAMFLGFLGAAGSTMG
AGSITLTVQARHLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARVLAVERYLRDQQ
LLGIWGCSGKLICTTTVPWNASWSNKSLNMIWNNMTWMQWEREIDNYTGIIYNLLEESQN
QQEKNEQELLELDKWANLWNWFDITQWLWYIRIFIMIVGGLVGLKIVFAVLSIVNRVRQG
YSPLSFQTHLPAPRGPDRPEGIEGEGGERDRDRSGGAVNGFLTLIWDDLWTLCSFSYHRL
RDLLLIVVRIVELLGRRGWEALKYWWNLLQYWSQELKNSAVSLLNTTAIAVAEGTDRIIE
VAQRILRAFLHIPRRIRQGLERALL
>tr|G1DTA3|G1DTA3_9PLVG Envelope glycoprotein gp160 OS=Simian-Human immunodeficiency virus OX=57667 GN=Env PE=3 SV=1
MRVKGIRKNYQHLWRGGTLLLGMLMICSAVEKLWVTVYYGVPVWKEATTTLFCASDAKAY
DTEVHNVWATHACVPTDPNPQEIVLENVTENFNMWKNNMVEQMHEDIISLWDQSLKPCVK
LTPLCVTLHCTNLKNATNTKSSNWKEMDRGEIKNCSFKVTTSIRNKMQKEYALFYKLDVV
PIDNDNTSYKLINCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNDKKFNGSGPCTNV
STVQCTHGIRPVVSTQLLLNGSLAEEGVVIRSENFTDNAKTIIVQLKESVEINCTRPNNN
TRKSITIGPGRAFYATGDIIGDIRQAHCNISGEKWNNTLKQIVTKLQAQFGNKTIVFKQS
SGGDPEIVMHSFNCGGEFFYCNSTQLFNSTWNNTIGPNNTNGTITLPCRIKQIINRWQEV
GKAMYAPPIRGQIRCSSNITGLLLTRDGGKEISNTTEIFRPGGGDMRDNWRSELYKYKVV
KIEPLGVAPTKAKRRVVQREKRAVTLGAMFLGFLGAAGSTMGAASLTLTVQARQLLSGIV
QQQNNLLRAIEAQQHLLQLTVWGIKQLQARVLAVERYLKDQQLLGIWGCSGKLICTTAVP
WNASWSNKSLDQIWNNMTWMEWEREIDNYTNLIYTLIEESQNQQEKNEQELLELDKWASL
WNWFDISKWLWYIKIFIMIVGGLVGLKIVFTVLSIVNRVRQGYSPLSFQTRFPAPRGPDR
PEGIEEEGGERDRDRSSPLVHGLLALIWDDLRSLCLFSYHRLRDLILIAARIVELLGRRG
WEALKYWGNLLQYWIQELKNSAVSLFDAIAIAVAEGTDRIIEVAQRIGRAFLHIPRRIRQ
GLERTLL
>sp|P12487|ENV_HV1Z2 Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype D (isolate Z2/CDC-Z34) OX=11683 GN=env PE=1 SV=1
MRVRGIERNCQNLWKWGIMLLGILMTCSNADNLWVTVYYGVPVWKEATTTLFCASDAKSY
KTEAHNIWATHACVPTDPNPQEIELENVTENFNMWRNNMVEQMHEDIISLWDQSLKPCVK
LTPLCVTLNCIDEVMENVTMKNNNVTEEIRMKNCSFNITTVVRDKTKQVHALFYRLDIVP
IDNDNSTNSTNYRLINCNTSAITQACPKVSFEPIPIHYCAPAGFAILKCRDKRFNGTGPC
TNVSTVQCTHGIRPVVSTQLLLNGSLAEEEIIIRSENLTNNAKIIIVQLNESVAINCTRP
YRNIRQRTSIGLGQALYTTKTRSIIGQAYCNISKNEWNKTLQQVAIKLGNLLNKTTIIFK
PSSGGDPEITTHSFNCGGEFFYCNTSGLFNSTWDISKSEWANSTESDDKPITLQCRIKQI
INMWQGVGKAMYAPPIEGQINCSSNITGLLLTRDGGTNNSSNETFRPGGGDMRDNWRSEL
YKYKVVKIEPLGVAPTRAKRRVVEREKRAIGLGAMFLGFLGAAGSTMGARSLTLTVQARQ
LLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKLI
CTTTVPWNSSWSNRSLNDIWQNMTWMEWEREIDNYTGLIYRLIEESQTQQEKNEQELLEL
DKWASLWNWFNITQWLWYIKIFIMIVGGLIGLRIVFAVLSLVNRVRQGYSPLSFQTLLPA
PRGPDRPEGIEEEGGERGRDRSIRLVNGFSALIWDDLRNLCLFSYHRLRDLILIAARIVE
LLGRRGWEALKYLWNLLQYWSRELKNSASSLLDTIAIAVAEGTDRVIEIVRRACRAVLHI
PTRIRQGLERLLL
>sp|P05882|ENV_HV1Z8 Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 1 group M subtype D (isolate Z84) OX=11681 GN=env PE=3 SV=1
MRVMGIRMNYQHLWKWGIMLLGILMTCSVAEDLWVTVYYGVPVWKEATTTLFCASDAKSY
EPEAHNIWATHACVPTDPNPREIEMENVTENFNMWKNNMVEQMHEDIISLWDQNLKPCVK
LTPLCVTLNCTNAGGNKTTNGNNTTNQEEQMMEKGEMKNCSFNITTVISDKKKQVHALFY
RLDVVPIDDDNSANTSNTNYTNYRLINCNTSAITQACPKVTFEPIPIHYCAPAGFAILKC
KDKKFNGTGPCKKVSTVQCTHGIRPVVSTQLLLNGSLAEEEIIIRSENLTNNVKTIIVHL
NESVEINCTRPDNKITRQSTPIGLGQALYTTRIKGDIRQAYCNISAAAWNKTLQQVAKKL
GDLLNQTTIIFKPPAGGDPEITTHSFNCGGEFFYCNTSRLFNSTWNSSTWNNDTLNSEGT
IKLPCRIKQIINMWQGVGKAMYAPPIEGLIKCTSNITGLLLTRDGGVNNSTNETFRPGGG
DMKDNWRNELYKYKVVRIEPLGIAPTRAKRRVVEREKRAIGLGAVFLGFLGAAGSTMGAV
SVALTGQARQLLSGIVQQQNNLLRAIEAQQHMLQLTVWGIKQLQARVLAVESYLKDQQLL
GIWGCSGKHICTTTVPWNSSWSNKSLEEIWNNMTWIEWEREIDNYTGVIYSLIENSQIQQ
EKNEQDLLQLDKWASLWNWFSITKWLWYIKIFIMIVGGLIGLRIVFTVLSLVNRVRQGYS
PLSFQTLLPAPRGPDRPEGIEEEGGEQGRDRSIRLVNGFSALFWDDLRNLCLFSYHRLRD
LILIATRIVELLGRRGWEAIKYLWSLLQYWTQELKNSFISLLNATAIAVAEGTDRIIELI
RRAFRAVLHIPRRVRQGLERALL
>sp|P18094|ENV_HV2BE Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 2 subtype A (isolate BEN) OX=11714 GN=env PE=3 SV=1
MEPGRNQLFVVILLTSACLVYCSQYVTVFYGIPAWKNASIPLFCATKNRDTWGTIQCLPD
NDDYQEIILNVTEAFDAWNNTVTEQAVEDVWHLFETSIKPCVKLTPLCVAMNCSRVQGNT
TTPNPRTSSSTTSRPPTSAASIINETSNCIENNTCAGLGYEEMMQCEFNMKGLEQDKKRR
YKDTWYLEDVVCDNTTAGTCYMRHCNTSIIKESCDKHYWDAMRFRYCAPPGFALLRCNDT
NYSGFEPKCTKVVAASCTRMMETQTSTWFGFNGTRAENRTYIYWHGRDNRTIISLNKYYN
LTMRCKRPGNKTVLPITLMSGLVFHSQPINTRPRQAWCRFGGRWREAMQEVKQTLVQHPR
YKGINDTGKINFTKPGAGSDPEVAFMWTNCRGEFLYCNMTWFLNWVEDKNQTRRNYCHIK
QIINTWHKVGKNVYLPPREGELACESTVTSIIANIDIDKNRTHTNITFSAEVAELYRLEL
GDYKLIEITPIGFAPTDQRRYSSTPVRNKRGVFVLGFLGFLATAGSAMGARSLTLSAQSR
TLLAGIVQQQQQLLDVVKRQQEMLRLTVWGTKNLQARVTAIEKYLKHQAQLNSWGCAFRQ
VCHTTVPWVNDSLSPDWKNMTWQEWEKQVRYLEANISQSLEEAQIQQEKNMYELQKLNSW
DILGNWFDLTSWVKYIQYGVHIVVGIIALRIAIYVVQLLSRFRKGYRPVFSSPPGYLQQI
HIHKDRGQPANEGTEEDVGGDSGYDLWPWPINYVQFLIHLLTRLLIGLYNICRDLLSKNS
PTRRLISQSLTAIRDWLRLKAAQLQYGCEWIQEAFQAFARTTRETLAGAWGWLWEAARRI
GRGILAVPRRIRQGAELALL
>sp|P17755|ENV_HV2D1 Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 2 subtype A (isolate D194) OX=11713 GN=env PE=3 SV=2
MEPGRNQLLVAILLTSACLIYCKQYVTVFYGIPAWRNASIPLFCATKNRDTWGTIQCLPD
NDDYQEITLNVTEAFDAWDNTVTEQAIEDVWRLFETSIKPCVKLTPLCVAMNCNITSGTT
ATPSPPNITIIDENSTCIGDNNCTGLGKEEVVECEFNMTGLEQDKKRKYNDAWYSRDVVC
DKTNGTGTCYMRHCNTSVIKESCDKHYWDAMKFRYCAPPGFALLRCNDTNYSGFEPKCSK
VVAASCTRMMETQTSTWFGFNGTRAENRTYIYWHGKDNRTIISLNKYYNLTMHCKRPGNK
TVVPITLMSGRRFHSRPVYNKKPGQAWCWFQGNWIEAMREVKQTLAKHPRYGGTNDTGKI
NFTKPGIGSDPEVTYMWTNCRGEFLYCNMTWFLNWVENKTNQTHGNYAPCHIRQIINTWH
KVGTNVYLPPREGELTCNSTVTSIIANIDSDGNQTNITFSAEVAELYRLELGDYKLIEVT
PIPFAPTKEKRYSSAPVRNKRGVFVLGFLGFLATAGSAMGGASLTLSAQSRTLLAGIVQQ
QQQLLDVVKRQQEMLRLTVWGTKNLQARVTAIEKYLKDQAQLNSWGCAFRQVCHTTVPWV
NDSLTPDWNNMTWQEWEKRVHYLEANISQSLEQAQIQQEKNMYELQKLNSWDVFGNWFDL
TSWIKYIQYGVYIVVGIIGLRIAIYIVQLLSRLRKGYRPVFSSPPGYLQQIHIHTDRGQP
ANEETEEDAGDDSGFGLWPWPLNYIQFLIHLLTRLLTGLYNSCRGLLSKNSPTRRLISQS
LTAIRDWLRLKAAYLQYGCEWIQEAFRAFARTARETIAGAWRGLCEAAQRIGRGILAVPR
RIRQGAEIALL
>sp|P05883|ENV_HV2NZ Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 2 subtype A (isolate NIH-Z) OX=11719 GN=env PE=1 SV=1
MKGSKNQLLIAIVLASAYLIHCKQFVTVFYGIPAWRNASIPLFCATKNRDTWGTIQCLPD
NDDYQEITLNVTEAFDAWNNTVTEQAVEDVWNLFETSIKPCVKLTPLCVAMNCTRNMTTW
TGRTDTQNITIINDTSHARADNCTGLKEEEMIDCQFSMTGLERDKRKQYTEAWYSKDVVC
DNNTSSQSKCYMNHCNTSVITESCDKHYWDAMRFRYCAPPGFALLRCNDTNYSGFAPNCS
KVVAATCTRMMETQTSTWFGFNGTRAENRTYIYWHGKDNRTIISLNNFYNLTMHCKRPGN
KTVLPITFMSGFKFHSQPVINKKPRQAWCWFEGQWKEAMQEVKETLAKHPRYKGNRSRTE
NIKFKAPGRGSDPEVTYMWTNCRGESLYCNMTWFLNWVENRTGQKQRNYAPCRIRQIINT
WHRVGKNLYLPPREGELTCNSTVTSIIANIDAGDQTNITFSAEAAELYRLELGDYKLVEI
TPIGFAPTSVKRYSSAHQRHTRGVFVLGFLGFLATAGSAMGAASLTLSAQSRTLLAGIVQ
QQQQLLDVVKRQQEMLRLTVWGTKNLQARVTAIEKYLKDQAQLNSWGCAFRQVCHTSVPW
VNDTLTPDWNNMTWQEWEQKVRYLEANISQSLEQAQIQQEKNMYELQKLNSWDVFTNWLD
FTSWVRYIQYGVYVVVGIVALRIVIYIVQMLSRLRKGYRPVFSSPPGYIQQIHIHKDQEQ
PAREETEEDVGSNGGDRSWPWPIAYIHFLIRLLIRLLTGLYNICRDLLSRISPILQPIFQ
SLQRALTAIRDWLRLKAAYLQYGCEWIQEAFQALARTTRETLAGAGRDLWRALQRIGRGI
LAVPRRIRQGAELALL
>sp|P32536|ENV_HV2S2 Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 2 subtype A (isolate ST/24.1C#2) OX=31681 GN=env PE=3 SV=1
MCGRNQLFVASLLASACLIYCVQYVTVFYGVPVWRNASIPLFCATKNRDTWGTIQCLPDN
DDYQEIALNVTEAFDAWNNTVTEQAVEDVWSLFETSIKPCVKLTPLCVAMRCNSTTAKNT
TSTPTTTTTANTTIGENSSCIRTDNCTGLGEEEMVDCQFNMTGLERDKKKLYNETWYSKD
VVCESKDTKKEKTCYMNHCNTSVITESCDKHYWDTMRFRYCAPPGFALLRCNDTNYSGFE
PNCSKVVAATCTRMMETQTSTWFGFNGTRAENRTYIYWHGRDNRTIISLNKFYNLTILCK
RPGNKTVVPITLMSGLVFHSQPINRRPRQAWCWFKGEWKEAMKEVKLTLAKHPRYKGTND
TEKIRFIAPGERSDPEVAYMWTNCRGEFLYCNMTWFLNWVENRTNQTQHNYVPCHIKQII
NTWHKVGKNVYLPPREGQLTCNSTVTSIIANIDGGENQTNITFSAEVAELYRLELGDYKL
IEVTPIGFAPTSIKRYSSAPVRNKRGVFVLGFLGFLTTAGAAMGAASLTLSAQSRTSLAG
IVQQQQQLLDVVKRQQEMLRLTVWGTKNLQARVTAIEKYLKDQAQLNSWGCAFRQVCHTT
VPWVNDTLTPDWNNITWQEWEQRIRNLEANISESLEQAQIQQEKNMYELQKLNSWDVFSN
WFDLTSWIKYIQYGVYIVVGIIVLRMVIYVVQMLSRLRKGYRPVFSSPPAYS
>sp|P12449|ENV_HV2SB Envelope glycoprotein gp160 OS=Human immunodeficiency virus type 2 subtype A (isolate SBLISY) OX=11718 GN=env PE=3 SV=1
MSGKIQLLVAFLLTSACLIYCTKYVTVFYGVPVWKNASIPLFCATKNRDTWGTIQCLPDN
DDYQEIPLNVTEAFDAWDNIVTEQAVEDVWNLFETSIKPCVKLTPLCVTMNCNASTESAV
ATTSPSGPDMINDTDPCIQLNNCSGLREEDMVECQFNMTGLELDKKKQYSETWYSKDVVC
ESDNSTDRKRCYMNHCNTSVITESCDKHYWDAMRFRYCAPPGFVLLRCNDTNYSGFEPNC
SKVVASTCTRMMETQPSTWLGFNGTRAENRTYIYWHGRDNRTIISLNKYYNLTILCRRPE
NKTVVPITLMSGRRFHSQKIINKKPRQAWCRFKGEWREAMQEVKQTLVKHPRYKGTNDTN
KINFTAPEKDSDPEVAYMWTNCRGEFLYCNMTWFLNWVENKTGQQHNYVPCHIEQIINTW
HKVGKNVYLPPREGELSCESTVTSIIANIDVDGDNRTNITFSAEVAELYRLELGDYKLVE
VTPIGFAPTAEKRYSSAPGRHKRGVLVLGFLGFLTTAGAAMGAASLTLSAQSRTLFRGIV
QQQQQLLDVVKRQQEMLRLTVWGTKNLQARVTAIEKYLADQARLNSWGCAFRQVCHTTVP
WVNDTLTPEWNNMTWQEWEHKIRFLEANISESLEQAQIQQEKNMYELQKLNSWDVFGNWF
DLTSWIKYIQYGVMIVVGIVALRIVIYVVQMLSRLRKGYRPVFSSPPGYIQQIHIHKDWE
QPDREETEEDVGNDVGSRSWPWPIEYIHFLIRLLIRLLTRLYNSCRDLLSRLYLILQPLR
DWLRLKAAYLQYGCEWIQEAFQALARVTRETLTSAGRSLWGALGRIGRGILAVPRRIRQG
AEIALL
>sp|P17281|ENV_SIVCZ Envelope glycoprotein gp160 OS=Simian immunodeficiency virus (isolate CPZ GAB1) OX=402771 GN=env PE=3 SV=1
MKVMEKKKRDWNSLSIITIITIILLTPCLTSELWVTVYYGVPVWHDADPVLFCASDAKAH
STEAHNIWATQACVPTDPSPQEVFLPNVIESFNMWKNNMVDQMHEDIISLWDQSLKPCVK
LTPLCVTLQCSKANFSQAKNLTNQTSSPPLEMKNCSFNVTTELRDKKKQVYSLFYVEDVV
NLGNENNTYRIINCNTTAITQACPKTSFEPIPIHYCAPAGFAILKCNDKDFSGKGKCTNV
STVHCTHGIKPVVTTQLLINGSLAEGNITVRVENKSKNTDVWIVQLVEAVSLNCHRPGNN
TRGEVQIGPGMTFYNIENVVGDTRSAYCKINGTTWNRTVEEVKKALATSSNRTAANITLN
RASGGDPEVTHHMFNCGGEFFYCNTSQIFTDNITNGIIILPCRIRQIVSSWMRVGRGIYA
PPIRGNITCNSNITGLLLTSDTPVTNNSGNLTFRPTGGNMKDIWRSELYKYKVVRIEPLS
VAPTKARRHTVARQKDRQKRAAFGLGALFLGFLGAAGSTMGAAAVTLTVQARQLLSGIVQ
QQNNLLKAIEAQQHLLQLSIWGVKQLQARLLAVERYLQDQQILGLWGCSGKAVCYTTVPW
NNSWPGSNSTDDIWGNLTWQQWDKLVSNYTGKIFGLLEEAQSQQEKNERDLLELDQWASL
WNWFDITKWLWYIKIFLMAVGGIIGLRIIMTVFSVVRRVRQGYSPLSLQTLIPVQREQGR
LGEIDEGGGEQDRSRSVRLVEGCLPLIWDDLRNLGIWSYQSLTSLACNVWRQLKTLGHLI
LHSLRLLRERLCLLGGIIQYWGKELKISAISLLDATAIAVAEGTDRIIEAFQVTLRIIRN
IPRRIRQGLERALL
>sp|P05885|ENV_SIVM1 Envelope glycoprotein gp160 OS=Simian immunodeficiency virus (isolate Mm142-83) OX=11733 GN=env PE=3 SV=1
MGCLGNQLLIAILLLSVYGIYCIQYVTVFYGVPAWRNATIPLFCATKNRDTWGTTQCLPD
NDDYSELALNVTESFDAWENTVTEQAIEDVWQLFETSIKPCVKLSPLCITMRCNKSETDK
WGLTKSSTTTASTTTTTTAKSVETRDIVNETSPCVVHDNCTGLEQEPMISCKFNMTGLKR
DKKKEYNETWYSADLVCEQGNSTGNESRCYMNHCNTSVIQECCDKDYWDAIRCRYCAPPG
YALLRCNDTNYSGFMPNCSKVVVSSCTRMMETQTSTWFRFNGTRAENRTYIYWHGRDNRT
IISLNKHYNLTMKCRRPGNKTVLPVTIMSALVFHSQPVNERPKQAWCRFGGNWKEAIKEV
KQTIVKHPRYTGTNNTDKINLTAPRGGDPEVTFMWTNCRGEFLYCKMNWFLNWVEDRSLT
TQKPKERHKRNYVPCHIRQIINTWHKVGKNVYLPPREGDLTCNSTVTSLIANINWTDGNQ
TSITMSAEVAELYRLELGDYKLVEITPIGLAPTNVKRYTTGGTSRNKRGVFVLGFLGFLA
TAGSAMGAASLTVTAQSRTLLAGIVQQQQQLLDVVKRQQELLRLTVWGTKNLQTRVSAIE
KYLKDQAQLNAWGCAFRQVCHTTVPWPNASLTPDWNNETWQEWERKVDFLEANITALLEE
AQIQQEKNMYELQKLNSWDVFGNWFDLTSWIKYIQYGIYIIVGVILLRIVIYIVQMLARL
RQGYRPVFSSPPSYFQXTHTQQDPALPTKEGKKGDGGGSGGNSSWPWQIEYIHFLIRQLI
RLLTWLFSNCRTLLSRAYQILQPIFQRLSATLRRIREVLRLELTYLQYGWSYFQEAVQAA
QRSATETLAGAWGELWEALQRGGRWILAIPRRIRQGLELTLL
>sp|P05884|ENV_SIVMK Envelope glycoprotein gp160 OS=Simian immunodeficiency virus (isolate K6W) OX=11735 GN=env PE=1 SV=1
MGCLGNQLLIAILLLSVYGIYCTQYVTVFYGVPAWRNATIPLFCATKNRDTWGTTQCLPD
NGDYSELALNVTESFDAWENTVTEQAIEDVWQLFETSIKPCVKLSPLCITMRCNKSETDR
WGLTKSSTTITTAAPTSAPVSEKIDMVNETSSCIAQNNCTGLEQEQMISCKFTMTGLKRD
KTKEYNETWYSTDLVCEQGNSTDNESRCYMNHCNTSVIQESCDKHYWDTIRFRYCAPPGY
ALLRCNDTNYSGFMPKCSKVVVSSCTRMMETQTSTWFGFNGTRAENRTYIYWHGRDNRTI
ISLNKYYNLTMKCRRPGNKTVLPVTIMSGLVFHSQPLTDRPKQAWCWFGGKWKDAIKEVK
QTIVKHPRYTGTNNTDKINLTAPGGGDPEVTFMWTNCRGEFLYCKMNWFLNWVEDRDVTT
QRPKERHRRNYVPCHIRQIINTWHKVGKNVYLPPREGDLTCNSTVTSLIANIDWTDGNQT
SITMSAEVAELYRLELGDYKLVEITPIGLAPTDVKRYTTGGTSRNKRGVFVLGFLGFLAT
AGSAMGAASFRLTAQSRTLLAGIVQQQQQLLGVVKRQQELLRLTVWGTKNLQTRVTAIEK
YLEDQAQLNAWGCAFRQVCHTTVPWPNASLTPDWNNDTWQEWERKVDFLEENITALLEEA
QIQQEKNMYELQKLNSWDVFGNWFDLASWIKYIQYGIYVVVGVILLRIVIYIVQMLAKLR
QGYRPVFSSPPSYFQXTHTQQDPALPTREGKEGDGGEGGGNSSWPWQIEYIHFLIRQLIR
LLTWLFSNCRTLLSRAYQILQPILQRLSATLRRIREVLRTELTYLQYGWSYFHEAVQAGW
RSATETLAGAWGDLWETLRRGGRWILAIPRRIRQGLELTLL
>sp|P11267|ENV_SIVML Envelope glycoprotein gp160 OS=Simian immunodeficiency virus (isolate K78) OX=11736 GN=env PE=3 SV=2
MGCLKNQLLIAILLLSVYGIYCTQYVTVFYGVPAWRNATIPLFCATKNRDTWGTTQCLPD
NGDYSELALNVTESFDAWENTVTEQAIEDVWQLFETSIKPCVKLSPLCITMRCNKSETDR
WGLTKSSTTITTAAPTSAPVSEKLDMVNETSSCIAQNNCTGLEQEQMISCKFNMTGLKRD
KTKEYNETWYSTDLVCEQRNSTDNESRCYMNHCNTSVIQESCDKHYWDTIRFRYCAPPGY
ALLRCNDTNYSGFMPKCSKVVVSSCTRMMETQTSTWFGFNGTRAENRTYIYWHGRDNRTI
ISLNKYYNLTMKCRRPGNKTVLPVTIMSELVFHSQPINDRPKQAWCWFGGKWKDAIKEVK
QTIVKHPRYTGTNNTDKINLTAPGGGDPEVTFMWTNCRGEFLYCKMNWFLNWVEDKDVTT
QRPKERHRKNYVPCHIRQIINTWHKVGKNVYLPPREGDLTCNSTVTSLIANIDWTDGNQT
SITMSAEVAELYRLELGDYKLVEITPIGLAPTDVKRYTTGGTSRNKRGVFVLGFLGFLAT
AGSAIGAVVVDVTAQSRTLLAGIVQQQQQLLDVVKRQQELLRLTVWGTKNLQTKVTAIEK
YLKDQAQLNAWGCAFRQVCHITVPWPNASLTPDWNNDTWQEWERKVDFLEENITALLEEA
QIQQEKNMYKLQKLNSWDVFGNWFDLASWIKYIQYGIYVVVGVILLRIVIYIVQMLAKLR
QGYRPVFSSPPSYFQXTHTQQDPALPTREGKEGDGGEGGGNSSWPWQIEYIHFLIRQLIR
LLTWLFSNCRTLLSRAYQILQPILQRLSATLRRIREVLRTELTYLQYGWSYFHEAVQAGW
RSATETLAGAWGDLWETLRRGGRWILAIPRRIRQGLELTLL
